| cellular process (GO:0009987) | 0.26 | 37 | L1CAM, GJC2, DDHD2, HSPD1, IBA57, B4GALNT1, KIF1A, ATL1, FA2H, CPT1C, SPAST, KIAA0196, AP5Z1, MAG, PLP1, CYP2U1, ARL6IP1, BSCL2, C12orf65, SPG20, TFG, PNPLA6, VPS37A, REEP1, NT5C2, ERLIN2, SPG11, ZFYVE26, TECPR2, DDHD1, ALDH18A1, GBA2, AMPD2, ZFYVE27, SPG7, KIF5A, CYP7B1 |
| single-organism process (GO:0044699) | 0.48 | 34 | L1CAM, GJC2, DDHD2, HSPD1, IBA57, B4GALNT1, KIF1A, ATL1, ENTPD1, CPT1C, SLC33A1, KIAA0196, PLP1, SPAST, CYP2U1, ARL6IP1, BSCL2, C12orf65, SPG20, FA2H, PNPLA6, ALDH18A1, NT5C2, ERLIN2, SPG11, ZFYVE26, MAG, DDHD1, GBA2, AMPD2, ZFYVE27, SPG7, KIF5A, CYP7B1 |
| single-organism cellular process (GO:0044763) | 0.65 | 29 | L1CAM, GJC2, BSCL2, HSPD1, IBA57, GBA2, KIF1A, ATL1, FA2H, CPT1C, KIAA0196, PLP1, SPAST, CYP2U1, ARL6IP1, C12orf65, SPG20, PNPLA6, ALDH18A1, NT5C2, SPG11, ZFYVE26, MAG, CYP7B1, B4GALNT1, AMPD2, ZFYVE27, SPG7, KIF5A |
| biological regulation (GO:0065007) | 0.39 | 23 | L1CAM, DDHD2, ENTPD1, SLC33A1, SPAST, RTN2, MAG, PLP1, ARL6IP1, BSCL2, C12orf65, SPG20, FA2H, REEP1, HSPD1, ERLIN2, TFG, DDHD1, B4GALNT1, AMPD2, SPG21, ZFYVE27, CYP7B1 |
| metabolic process (GO:0008152) | 0.58 | 23 | BSCL2, HSPD1, IBA57, B4GALNT1, FA2H, CPT1C, SPAST, AP5Z1, CYP2U1, PLP1, DDHD2, C12orf65, PNPLA6, ALDH18A1, NT5C2, ERLIN2, ZFYVE26, DDHD1, VPS37A, GBA2, AMPD2, SPG7, CYP7B1 |
| organic substance metabolic process (GO:0071704) | 0.63 | 22 | BSCL2, HSPD1, IBA57, B4GALNT1, FA2H, CPT1C, PLP1, AP5Z1, CYP2U1, DDHD2, C12orf65, PNPLA6, ALDH18A1, NT5C2, ERLIN2, ZFYVE26, DDHD1, VPS37A, GBA2, AMPD2, SPG7, CYP7B1 |
| primary metabolic process (GO:0044238) | 0.69 | 21 | ZFYVE26, FA2H, PLP1, NT5C2, GBA2, CPT1C, ALDH18A1, DDHD1, C12orf65, DDHD2, AP5Z1, PNPLA6, AMPD2, CYP7B1, VPS37A, BSCL2, B4GALNT1, HSPD1, SPG7, CYP2U1, ERLIN2 |
| localization (GO:0051179) | 1.4 | 21 | AP4S1, KIF1A, ARL6IP1, NIPA1, SPAST, SLC33A1, KIF5A, KIAA0196, RTN2, REEP1, VPS37A, AP4M1, B4GALNT1, AP5Z1, AP4B1, AP4E1, ZFYVE27, GJC2, SPG7, SPG11, BSCL2 |
| regulation of biological process (GO:0050789) | 0.45 | 20 | TFG, PLP1, DDHD2, REEP1, ARL6IP1, SPG21, SLC33A1, DDHD1, C12orf65, SPG20, FA2H, RTN2, MAG, SPAST, ZFYVE27, HSPD1, L1CAM, ERLIN2, BSCL2, CYP7B1 |
| cellular metabolic process (GO:0044237) | 0.69 | 20 | ZFYVE26, FA2H, PLP1, PNPLA6, CPT1C, C12orf65, DDHD1, DDHD2, VPS37A, B4GALNT1, AMPD2, NT5C2, AP5Z1, ALDH18A1, IBA57, GBA2, HSPD1, ERLIN2, CYP2U1, CYP7B1 |
| establishment of localization (GO:0051234) | 1.48 | 18 | AP4S1, KIF1A, NIPA1, ARL6IP1, SPAST, SLC33A1, KIF5A, KIAA0196, RTN2, AP5Z1, AP4E1, VPS37A, AP4B1, AP4M1, REEP1, GJC2, SPG7, SPG11 |
| single-organism metabolic process (GO:0044710) | 1.63 | 17 | FA2H, GBA2, CPT1C, BSCL2, DDHD1, DDHD2, PLP1, B4GALNT1, AMPD2, NT5C2, ALDH18A1, IBA57, PNPLA6, HSPD1, ERLIN2, CYP2U1, CYP7B1 |
| transport (GO:0006810) | 1.51 | 17 | AP4S1, KIF1A, ARL6IP1, GJC2, SLC33A1, KIF5A, KIAA0196, RTN2, AP5Z1, AP4M1, SPAST, AP4B1, AP4E1, NIPA1, SPG7, VPS37A, SPG11 |
| regulation of cellular process (GO:0050794) | 0.5 | 17 | TFG, L1CAM, ARL6IP1, SPAST, SLC33A1, DDHD2, C12orf65, SPG20, FA2H, MAG, CYP7B1, PLP1, ZFYVE27, SPG21, HSPD1, ERLIN2, DDHD1 |
| cellular component organization (GO:0016043) | 1.24 | 16 | TFG, PLP1, REEP1, ARL6IP1, SPAST, BSCL2, KIAA0196, SPG20, FA2H, VPS37A, IBA57, ZFYVE27, HSPD1, ATL1, SPG7, C12orf65 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 16 | TFG, PLP1, REEP1, ARL6IP1, BSCL2, C12orf65, SPG20, FA2H, SPAST, IBA57, ZFYVE27, HSPD1, ATL1, SPG7, VPS37A, KIAA0196 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 13 | ZFYVE26, FA2H, GBA2, CPT1C, C12orf65, AP5Z1, B4GALNT1, AMPD2, NT5C2, ALDH18A1, IBA57, PNPLA6, HSPD1 |
| positive regulation of biological process (GO:0048518) | 1.2 | 12 | TFG, PLP1, L1CAM, ARL6IP1, DDHD1, DDHD2, SPG21, MAG, SPAST, HSPD1, ERLIN2, CYP7B1 |
| developmental process (GO:0032502) | 1.36 | 12 | MAG, L1CAM, CYP7B1, SPG20, PLP1, PNPLA6, KIAA0196, SPAST, GBA2, SPG7, SPG11, ATL1 |
| lipid metabolic process (GO:0006629) | 2.68 | 12 | FA2H, GBA2, CPT1C, BSCL2, DDHD1, DDHD2, CYP2U1, B4GALNT1, PLP1, PNPLA6, ERLIN2, CYP7B1 |
| cellular localization (GO:0051641) | 2.32 | 12 | KIF1A, ARL6IP1, SPG11, RTN2, VPS37A, AP4M1, SPAST, AP4B1, AP4E1, ZFYVE27, SPG7, KIF5A |
| macromolecule localization (GO:0033036) | 2.34 | 11 | AP4S1, AP4M1, ARL6IP1, AP4B1, KIAA0196, AP5Z1, AP4E1, VPS37A, RTN2, ZFYVE27, KIF5A |
| protein localization (GO:0008104) | 2.36 | 11 | AP4S1, ARL6IP1, AP4B1, KIAA0196, RTN2, AP5Z1, AP4M1, VPS37A, AP4E1, ZFYVE27, KIF5A |
| intracellular transport (GO:0046907) | 2.67 | 11 | KIF1A, ARL6IP1, SPG11, AP4B1, RTN2, VPS37A, AP4M1, SPAST, AP4E1, SPG7, KIF5A |
| establishment of localization in cell (GO:0051649) | 2.47 | 11 | KIF1A, ARL6IP1, SPG11, AP4B1, RTN2, VPS37A, AP4M1, SPAST, AP4E1, SPG7, KIF5A |
| organelle organization (GO:0006996) | 2.02 | 10 | TFG, ARL6IP1, BSCL2, KIAA0196, SPG20, VPS37A, SPAST, REEP1, SPG7, ATL1 |
| establishment of protein localization (GO:0045184) | 2.53 | 10 | AP4S1, ARL6IP1, KIAA0196, AP4E1, AP5Z1, RTN2, VPS37A, AP4M1, REEP1, AP4B1 |
| organic substance biosynthetic process (GO:1901576) | 1.34 | 10 | FA2H, C12orf65, DDHD1, DDHD2, ALDH18A1, B4GALNT1, AMPD2, PLP1, IBA57, CYP7B1 |
| cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 10 | ZFYVE26, CPT1C, C12orf65, B4GALNT1, AMPD2, NT5C2, AP5Z1, IBA57, GBA2, HSPD1 |
| single-organism developmental process (GO:0044767) | 1.49 | 10 | MAG, L1CAM, CYP7B1, PLP1, PNPLA6, SPAST, GBA2, ATL1, SPG11, KIAA0196 |
| biosynthetic process (GO:0009058) | 1.32 | 10 | FA2H, C12orf65, DDHD1, DDHD2, ALDH18A1, B4GALNT1, AMPD2, PLP1, IBA57, CYP7B1 |
| small molecule metabolic process (GO:0044281) | 2.38 | 10 | FA2H, CPT1C, CYP7B1, ALDH18A1, GBA2, AMPD2, PLP1, NT5C2, ERLIN2, CYP2U1 |
| organic substance transport (GO:0071702) | 2.15 | 10 | AP4S1, ARL6IP1, SLC33A1, KIAA0196, AP4E1, VPS37A, RTN2, AP5Z1, AP4M1, AP4B1 |
| organic substance catabolic process (GO:1901575) | 2.45 | 9 | CPT1C, BSCL2, DDHD1, DDHD2, PNPLA6, VPS37A, GBA2, NT5C2, ERLIN2 |
| organonitrogen compound metabolic process (GO:1901564) | 2.32 | 9 | FA2H, CPT1C, C12orf65, B4GALNT1, AMPD2, ALDH18A1, IBA57, GBA2, NT5C2 |
| protein transport (GO:0015031) | 2.62 | 9 | AP4S1, ARL6IP1, KIAA0196, RTN2, VPS37A, AP4E1, AP5Z1, AP4M1, AP4B1 |
| catabolic process (GO:0009056) | 2.38 | 9 | CPT1C, BSCL2, DDHD1, DDHD2, PNPLA6, VPS37A, GBA2, NT5C2, ERLIN2 |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 9 | ZFYVE26, CYP7B1, GBA2, AMPD2, NT5C2, AP5Z1, IBA57, HSPD1, ERLIN2 |
| positive regulation of cellular process (GO:0048522) | 1.3 | 9 | TFG, L1CAM, DDHD1, DDHD2, MAG, SPAST, HSPD1, ERLIN2, CYP7B1 |
| macromolecule metabolic process (GO:0043170) | 0.83 | 8 | ZFYVE26, C12orf65, AP5Z1, B4GALNT1, VPS37A, HSPD1, SPG7, ERLIN2 |
| cellular biosynthetic process (GO:0044249) | 1.37 | 8 | FA2H, CYP7B1, ALDH18A1, B4GALNT1, AMPD2, PLP1, IBA57, C12orf65 |
| cellular component assembly (GO:0022607) | 2.14 | 8 | TFG, ARL6IP1, KIAA0196, VPS37A, SPAST, IBA57, HSPD1, ATL1 |
| regulation of metabolic process (GO:0019222) | 1.02 | 8 | ARL6IP1, SLC33A1, BSCL2, C12orf65, SPG20, PLP1, HSPD1, ERLIN2 |
| cellular developmental process (GO:0048869) | 1.82 | 8 | FA2H, L1CAM, KIAA0196, BSCL2, PLP1, GBA2, SPAST, ATL1 |
| single-organism catabolic process (GO:0044712) | 3.21 | 7 | CPT1C, BSCL2, DDHD1, DDHD2, PNPLA6, GBA2, NT5C2 |
| single-organism biosynthetic process (GO:0044711) | 2.8 | 7 | FA2H, CYP7B1, ALDH18A1, B4GALNT1, AMPD2, PLP1, IBA57 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 7 | ARL6IP1, SLC33A1, BSCL2, C12orf65, SPG20, HSPD1, ERLIN2 |
| organic acid metabolic process (GO:0006082) | 3.01 | 7 | FA2H, CPT1C, CYP7B1, PLP1, GBA2, ALDH18A1, CYP2U1 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 7 | ARL6IP1, SLC33A1, C12orf65, SPG20, PLP1, HSPD1, ERLIN2 |
| response to stimulus (GO:0050896) | 1.22 | 7 | ZFYVE26, MAG, GJC2, PLP1, AP5Z1, HSPD1, ERLIN2 |
| anatomical structure development (GO:0048856) | 1.58 | 7 | MAG, L1CAM, SPG20, PLP1, GBA2, SPAST, SPG7 |
| carboxylic acid metabolic process (GO:0019752) | 3.12 | 7 | FA2H, CPT1C, CYP7B1, PLP1, GBA2, ALDH18A1, CYP2U1 |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 7 | MAG, L1CAM, SPG11, SPAST, KIF1A, SPG7, KIF5A |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 7 | ZFYVE26, C12orf65, VPS37A, B4GALNT1, AP5Z1, HSPD1, ERLIN2 |
| signal transduction (GO:0007165) | 1.28 | 7 | TFG, SLC33A1, PLP1, SPG21, ZFYVE27, HSPD1, ERLIN2 |
| phosphorus metabolic process (GO:0006793) | 2.15 | 7 | DDHD1, DDHD2, PNPLA6, AMPD2, ALDH18A1, NT5C2, ERLIN2 |
| oxoacid metabolic process (GO:0043436) | 3.12 | 7 | FA2H, CPT1C, CYP7B1, PLP1, GBA2, ALDH18A1, CYP2U1 |
| negative regulation of biological process (GO:0048519) | 1.33 | 7 | MAG, ARL6IP1, BSCL2, CYP7B1, SPG20, HSPD1, ERLIN2 |
| cellular lipid metabolic process (GO:0044255) | 2.92 | 7 | FA2H, GBA2, CPT1C, CYP2U1, PNPLA6, PLP1, B4GALNT1 |
| single-organism localization (GO:1902578) | 2.09 | 7 | KIF1A, ARL6IP1, SLC33A1, SPAST, ZFYVE27, SPG7, SPG11 |
| multicellular organismal process (GO:0032501) | 1.45 | 6 | ENTPD1, L1CAM, SPG20, AMPD2, SPAST, HSPD1 |
| vesicle-mediated transport (GO:0016192) | 2.72 | 6 | KIF5A, AP4E1, SPAST, AP4B1, AP4M1, SPG11 |
| organonitrogen compound biosynthetic process (GO:1901566) | 2.85 | 6 | FA2H, C12orf65, B4GALNT1, AMPD2, ALDH18A1, IBA57 |
| protein metabolic process (GO:0019538) | 1.45 | 6 | C12orf65, B4GALNT1, VPS37A, HSPD1, ERLIN2, SPG7 |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 6 | ZFYVE26, AMPD2, NT5C2, AP5Z1, IBA57, HSPD1 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 6 | ARL6IP1, SLC33A1, C12orf65, SPG20, HSPD1, ERLIN2 |
| regulation of cellular component organization (GO:0051128) | 2.01 | 6 | MAG, L1CAM, SPG20, DDHD1, DDHD2, SPAST |
| cellular catabolic process (GO:0044248) | 2.62 | 6 | CPT1C, PNPLA6, VPS37A, GBA2, NT5C2, ERLIN2 |
| single-organism transport (GO:0044765) | 2.18 | 6 | KIF1A, ARL6IP1, SLC33A1, SPAST, SPG7, SPG11 |
| microtubule-based process (GO:0007017) | 3.54 | 6 | KIF1A, KIF5A, KIAA0196, SPAST, SPG7, SPG11 |
| regulation of biological quality (GO:0065008) | 1.68 | 6 | ENTPD1, SPG20, BSCL2, B4GALNT1, AMPD2, HSPD1 |
| monocarboxylic acid metabolic process (GO:0032787) | 3.57 | 6 | CYP2U1, CPT1C, CYP7B1, FA2H, GBA2, PLP1 |
| single-organism cellular localization (GO:1902580) | 3.16 | 6 | KIF1A, ARL6IP1, SPAST, ZFYVE27, SPG7, SPG11 |
| lipid catabolic process (GO:0016042) | 4.21 | 6 | CPT1C, DDHD2, DDHD1, BSCL2, PNPLA6, GBA2 |
| negative regulation of cellular process (GO:0048523) | 1.41 | 6 | MAG, ARL6IP1, CYP7B1, SPG20, HSPD1, ERLIN2 |
| heterocycle metabolic process (GO:0046483) | 1.31 | 6 | ZFYVE26, AMPD2, NT5C2, AP5Z1, IBA57, HSPD1 |
| nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 5 | AMPD2, NT5C2, AP5Z1, HSPD1, ZFYVE26 |
| cell differentiation (GO:0030154) | 2.14 | 5 | L1CAM, PLP1, BSCL2, FA2H, SPAST |
| protein complex subunit organization (GO:0071822) | 2.6 | 5 | C12orf65, ATL1, SPAST, HSPD1, TFG |
| single-multicellular organism process (GO:0044707) | 1.78 | 5 | AMPD2, HSPD1, SPAST, L1CAM, ENTPD1 |
| membrane organization (GO:0061024) | 3.04 | 5 | VPS37A, FA2H, ARL6IP1, SPAST, ZFYVE27 |
| regulation of developmental process (GO:0050793) | 2.1 | 5 | DDHD2, DDHD1, L1CAM, SPG20, MAG |
| microtubule-based movement (GO:0007018) | 4.39 | 5 | SPG11, SPAST, KIF5A, SPG7, KIF1A |
| intracellular protein transport (GO:0006886) | 3.2 | 5 | ARL6IP1, RTN2, AP4B1, AP4E1, AP4M1 |
| regulation of anatomical structure morphogenesis (GO:0022603) | 2.79 | 5 | SPG20, DDHD2, DDHD1, L1CAM, MAG |
| regulation of response to stimulus (GO:0048583) | 1.54 | 5 | HSPD1, TFG, SPG20, CYP7B1, SPG21 |
| response to stress (GO:0006950) | 1.8 | 5 | HSPD1, ZFYVE26, AP5Z1, PLP1, ERLIN2 |
| cytoskeleton-dependent intracellular transport (GO:0030705) | 4.96 | 5 | SPG11, SPAST, KIF5A, SPG7, KIF1A |
| immune system process (GO:0002376) | 2.29 | 5 | HSPD1, KIF5A, MAG, L1CAM, SPG21 |
| macromolecular complex subunit organization (GO:0043933) | 2.14 | 5 | HSPD1, ATL1, TFG, SPAST, C12orf65 |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 5 | AMPD2, NT5C2, ALDH18A1, ERLIN2, PNPLA6 |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 5 | HSPD1, SPG20, FA2H, L1CAM, MAG |
| cell adhesion (GO:0007155) | 2.82 | 5 | HSPD1, MAG, SPG7, L1CAM, ENTPD1 |
| single-organism intracellular transport (GO:1902582) | 3.59 | 5 | KIF1A, SPG7, SPG11, SPAST, ARL6IP1 |
| biological adhesion (GO:0022610) | 2.81 | 5 | HSPD1, SPG7, MAG, L1CAM, ENTPD1 |
| regulation of gene expression (GO:0010468) | 1.37 | 5 | ERLIN2, SLC33A1, PLP1, SPG20, C12orf65 |
| oxidation-reduction process (GO:0055114) | 2.91 | 5 | CYP7B1, FA2H, CYP2U1, ALDH18A1, CPT1C |
| fatty acid metabolic process (GO:0006631) | 4.03 | 4 | PLP1, CYP2U1, FA2H, CPT1C |
| cell projection organization (GO:0030030) | 3.14 | 4 | PLP1, ATL1, ZFYVE27, SPAST |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 4 | SLC33A1, ERLIN2, SPG20, C12orf65 |
| signaling (GO:0023052) | 3.25 | 4 | KIF5A, PLP1, SPG11, GJC2 |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 4 | SLC33A1, PLP1, SPG21, ZFYVE27 |
| small molecule biosynthetic process (GO:0044283) | 3.79 | 4 | CYP7B1, PLP1, FA2H, ALDH18A1 |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 4 | ATL1, SPAST, CYP7B1, PNPLA6 |
| cellular response to stimulus (GO:0051716) | 1.97 | 4 | ZFYVE26, ERLIN2, AP5Z1, MAG |
| regulation of cellular macromolecule biosynthetic process (GO:2000112) | 1.46 | 4 | SLC33A1, C12orf65, SPG20, ERLIN2 |
| axo-dendritic transport (GO:0008088) | 6.12 | 4 | KIF1A, SPAST, SPG11, SPG7 |
| macromolecular complex assembly (GO:0065003) | 2.55 | 4 | HSPD1, ATL1, TFG, SPAST |
| positive regulation of cellular component organization (GO:0051130) | 2.68 | 4 | L1CAM, DDHD1, DDHD2, SPAST |
| protein complex assembly (GO:0006461) | 2.78 | 4 | HSPD1, ATL1, TFG, SPAST |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 4 | SLC33A1, ERLIN2, SPG20, C12orf65 |
| establishment of localization by movement along microtubule (GO:0010970) | 5.14 | 4 | KIF1A, SPAST, SPG11, SPG7 |
| single-organism membrane organization (GO:0044802) | 3.19 | 4 | SPAST, FA2H, ARL6IP1, ZFYVE27 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 4 | SLC33A1, ERLIN2, SPG20, C12orf65 |
| cell-cell signaling (GO:0007267) | 3.35 | 4 | SPG11, PLP1, KIF5A, GJC2 |
| cell communication (GO:0007154) | 3.04 | 4 | SPG11, PLP1, KIF5A, GJC2 |
| transmembrane transport (GO:0055085) | 2.72 | 4 | SLC33A1, RTN2, GJC2, NIPA1 |
| lipid biosynthetic process (GO:0008610) | 3.49 | 4 | PLP1, FA2H, CYP7B1, B4GALNT1 |
| endosomal transport (GO:0016197) | 4.28 | 4 | KIAA0196, AP5Z1, VPS37A, AP4M1 |
| single organism signaling (GO:0044700) | 3.25 | 4 | KIF5A, PLP1, SPG11, GJC2 |
| cellular nitrogen compound biosynthetic process (GO:0044271) | 1.59 | 4 | AMPD2, C12orf65, IBA57, B4GALNT1 |
| nervous system development (GO:0007399) | 3.53 | 4 | SPG7, MAG, L1CAM, SPAST |
| vacuolar transport (GO:0007034) | 4.18 | 4 | KIAA0196, VPS37A, AP5Z1, AP4M1 |
| positive regulation of developmental process (GO:0051094) | 2.77 | 4 | L1CAM, DDHD1, DDHD2, MAG |
| carboxylic acid biosynthetic process (GO:0046394) | 4.32 | 4 | ALDH18A1, PLP1, FA2H, CYP7B1 |
| carbohydrate derivative metabolic process (GO:1901135) | 3.07 | 4 | AMPD2, NT5C2, B4GALNT1, GBA2 |
| organic acid biosynthetic process (GO:0016053) | 4.26 | 4 | ALDH18A1, PLP1, FA2H, CYP7B1 |
| regulation of macromolecule biosynthetic process (GO:0010556) | 1.43 | 4 | SLC33A1, C12orf65, SPG20, ERLIN2 |
| system development (GO:0048731) | 2.92 | 4 | SPG7, MAG, L1CAM, SPAST |
| regulation of cell morphogenesis (GO:0022604) | 3.4 | 3 | L1CAM, MAG, SPG20 |
| negative regulation of metabolic process (GO:0009892) | 1.93 | 3 | ERLIN2, BSCL2, ARL6IP1 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 3 | HSPD1, ERLIN2, PLP1 |
| regulation of organelle organization (GO:0033043) | 2.72 | 3 | DDHD1, DDHD2, SPAST |
| regulation of transport (GO:0051049) | 2.24 | 3 | RTN2, ARL6IP1, REEP1 |
| chemical synaptic transmission (GO:0007268) | 3.98 | 3 | KIF5A, PLP1, SPG11 |
| nucleic acid metabolic process (GO:0090304) | 1.46 | 3 | HSPD1, ZFYVE26, AP5Z1 |
| cell cycle process (GO:0022402) | 2.75 | 3 | ZFYVE26, SPAST, KIAA0196 |
| regulation of signaling (GO:0023051) | 1.72 | 3 | CYP7B1, SPG20, TFG |
| cellular lipid catabolic process (GO:0044242) | 4.73 | 3 | PNPLA6, GBA2, CPT1C |
| glycosyl compound metabolic process (GO:1901657) | 4.04 | 3 | AMPD2, NT5C2, GBA2 |
| organic cyclic compound biosynthetic process (GO:1901362) | 1.66 | 3 | AMPD2, CYP7B1, IBA57 |
| regulation of cell projection organization (GO:0031344) | 3.38 | 3 | SPG20, MAG, L1CAM |
| cell division (GO:0051301) | 3.68 | 3 | ZFYVE26, SPAST, SPG20 |
| cellular protein metabolic process (GO:0044267) | 1.63 | 3 | ERLIN2, C12orf65, B4GALNT1 |
| endoplasmic reticulum organization (GO:0007029) | 6.26 | 3 | ATL1, ARL6IP1, REEP1 |
| regulation of cell communication (GO:0010646) | 1.73 | 3 | TFG, SPG20, CYP7B1 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 3 | HSPD1, PLP1, ERLIN2 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 2.24 | 3 | SLC33A1, ERLIN2, SPG20 |
| regulation of signal transduction (GO:0009966) | 1.84 | 3 | TFG, SPG20, CYP7B1 |
| positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 3 | HSPD1, MAG, L1CAM |
| Golgi vesicle transport (GO:0048193) | 4.07 | 3 | SPAST, KIF5A, AP4M1 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 3 | HSPD1, C12orf65, ARL6IP1 |
| regulation of cell development (GO:0060284) | 3.01 | 3 | SPG20, MAG, L1CAM |
| anterograde axonal transport (GO:0008089) | 6.47 | 3 | SPAST, KIF1A, SPG7 |
| regulation of neuron differentiation (GO:0045664) | 3.39 | 3 | SPG20, MAG, L1CAM |
| regulation of cell morphogenesis involved in differentiation (GO:0010769) | 3.91 | 3 | L1CAM, MAG, SPG20 |
| phosphorylation (GO:0016310) | 2.63 | 3 | NT5C2, ALDH18A1, ERLIN2 |
| organophosphate metabolic process (GO:0019637) | 3.04 | 3 | AMPD2, NT5C2, PNPLA6 |
| sphingolipid metabolic process (GO:0006665) | 4.79 | 3 | FA2H, B4GALNT1, GBA2 |
| DNA recombination (GO:0006310) | 4.39 | 3 | HSPD1, ZFYVE26, AP5Z1 |
| positive regulation of response to stimulus (GO:0048584) | 2.18 | 3 | HSPD1, TFG, SPG21 |
| membrane lipid metabolic process (GO:0006643) | 4.51 | 3 | FA2H, B4GALNT1, GBA2 |
| regulation of neurogenesis (GO:0050767) | 3.21 | 3 | SPG20, MAG, L1CAM |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 3 | SLC33A1, ERLIN2, SPG20 |
| regulation of nucleic acid-templated transcription (GO:1903506) | 1.55 | 3 | SLC33A1, ERLIN2, SPG20 |
| reproductive process (GO:0022414) | 2.55 | 3 | CYP7B1, KIAA0196, B4GALNT1 |
| regulation of cell differentiation (GO:0045595) | 2.42 | 3 | L1CAM, MAG, SPG20 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 3 | HSPD1, C12orf65, ARL6IP1 |
| regulation of neuron projection development (GO:0010975) | 3.69 | 3 | L1CAM, MAG, SPG20 |
| regulation of RNA biosynthetic process (GO:2001141) | 1.55 | 3 | SLC33A1, ERLIN2, SPG20 |
| regulation of localization (GO:0032879) | 1.94 | 3 | ARL6IP1, RTN2, REEP1 |
| lipid modification (GO:0030258) | 4.37 | 3 | FA2H, B4GALNT1, CPT1C |
| proteolysis (GO:0006508) | 2.73 | 3 | SPG7, VPS37A, ERLIN2 |
| steroid metabolic process (GO:0008202) | 4.32 | 3 | CYP7B1, ERLIN2, GBA2 |
| anterograde trans-synaptic signaling (GO:0098916) | 3.98 | 3 | SPG11, PLP1, KIF5A |
| single organism reproductive process (GO:0044702) | 2.73 | 3 | CYP7B1, KIAA0196, B4GALNT1 |
| regulation of axonogenesis (GO:0050770) | 4.59 | 3 | L1CAM, MAG, SPG20 |
| cellular amide metabolic process (GO:0043603) | 3.23 | 3 | C12orf65, B4GALNT1, GBA2 |
| regulation of RNA metabolic process (GO:0051252) | 1.52 | 3 | SLC33A1, ERLIN2, SPG20 |
| positive regulation of organelle organization (GO:0010638) | 3.38 | 3 | DDHD1, DDHD2, SPAST |
| (GO:0098930) | 6.26 | 3 | SPAST, KIF1A, SPG7 |
| monocarboxylic acid biosynthetic process (GO:0072330) | 4.74 | 3 | PLP1, FA2H, CYP7B1 |
| regulation of transcription, DNA-templated (GO:0006355) | 1.56 | 3 | SLC33A1, ERLIN2, SPG20 |
| single-organism organelle organization (GO:1902589) | 2.68 | 3 | SPAST, KIAA0196, ARL6IP1 |
| regulation of nervous system development (GO:0051960) | 3.1 | 3 | L1CAM, MAG, SPG20 |
| regulation of multicellular organismal development (GO:2000026) | 2.31 | 3 | SPG20, MAG, L1CAM |
| cellular response to stress (GO:0033554) | 2.51 | 3 | ZFYVE26, AP5Z1, ERLIN2 |
| DNA metabolic process (GO:0006259) | 3.09 | 3 | HSPD1, ZFYVE26, AP5Z1 |
| cytokinesis (GO:0000910) | 5.22 | 3 | ZFYVE26, KIAA0196, SPAST |
| synaptic signaling (GO:0099536) | 3.98 | 3 | SPG11, PLP1, KIF5A |
| trans-synaptic signaling (GO:0099537) | 3.98 | 3 | SPG11, PLP1, KIF5A |
| organophosphate catabolic process (GO:0046434) | 5.03 | 2 | NT5C2, PNPLA6 |
| negative regulation of response to stimulus (GO:0048585) | 2.52 | 2 | CYP7B1, SPG20 |
| cell development (GO:0048468) | 3.28 | 2 | PLP1, GBA2 |
| cell maturation (GO:0048469) | 4.98 | 2 | PLP1, KIAA0196 |
| purine ribonucleoside monophosphate metabolic process (GO:0009167) | 4.7 | 2 | AMPD2, NT5C2 |
| plasma membrane organization (GO:0007009) | 4.8 | 2 | FA2H, ZFYVE27 |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 3.24 | 2 | SLC33A1, ZFYVE27 |
| establishment of organelle localization (GO:0051656) | 4.15 | 2 | SPAST, SPG11 |
| negative regulation of cell projection organization (GO:0031345) | 4.72 | 2 | MAG, SPG20 |
| purine ribonucleoside metabolic process (GO:0046128) | 4.33 | 2 | AMPD2, NT5C2 |
| double-strand break repair (GO:0006302) | 4.73 | 2 | ZFYVE26, AP5Z1 |
| negative regulation of signal transduction (GO:0009968) | 2.75 | 2 | CYP7B1, SPG20 |
| cellular macromolecule localization (GO:0070727) | 3.1 | 2 | ARL6IP1, ZFYVE27 |
| negative regulation of neuron differentiation (GO:0045665) | 4.45 | 2 | MAG, SPG20 |
| negative regulation of lipid metabolic process (GO:0045833) | 5.33 | 2 | ERLIN2, BSCL2 |
| positive regulation of cell development (GO:0010720) | 3.57 | 2 | MAG, L1CAM |
| negative regulation of cell development (GO:0010721) | 4.02 | 2 | MAG, SPG20 |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281) | 4.43 | 2 | HSPD1, ARL6IP1 |
| glycolipid metabolic process (GO:0006664) | 5.01 | 2 | B4GALNT1, GBA2 |
| regulation of cell proliferation (GO:0042127) | 2.41 | 2 | CYP7B1, FA2H |
| negative regulation of developmental process (GO:0051093) | 3.17 | 2 | MAG, SPG20 |
| DNA repair (GO:0006281) | 3.59 | 2 | ZFYVE26, AP5Z1 |
| negative regulation of cell death (GO:0060548) | 2.95 | 2 | HSPD1, ARL6IP1 |
| secondary alcohol metabolic process (GO:1902652) | 5.0 | 2 | CYP7B1, ERLIN2 |
| regulation of proteolysis (GO:0030162) | 3.2 | 2 | HSPD1, ARL6IP1 |
| protein localization to membrane (GO:0072657) | 3.95 | 2 | ARL6IP1, ZFYVE27 |
| neuron projection guidance (GO:0097485) | 4.43 | 2 | L1CAM, KIF5A |
| multi-organism process (GO:0051704) | 2.65 | 2 | HSPD1, VPS37A |
| organonitrogen compound catabolic process (GO:1901565) | 3.91 | 2 | NT5C2, GBA2 |
| cell motility (GO:0048870) | 3.02 | 2 | MAG, L1CAM |
| vesicle organization (GO:0016050) | 4.13 | 2 | TFG, VPS37A |
| purine nucleotide metabolic process (GO:0006163) | 4.09 | 2 | AMPD2, NT5C2 |
| aromatic compound biosynthetic process (GO:0019438) | 1.7 | 2 | AMPD2, IBA57 |
| ceramide metabolic process (GO:0006672) | 5.41 | 2 | B4GALNT1, GBA2 |
| cell part morphogenesis (GO:0032990) | 3.99 | 2 | SPAST, ATL1 |
| ribonucleoside monophosphate metabolic process (GO:0009161) | 4.62 | 2 | AMPD2, NT5C2 |
| positive regulation of gene expression (GO:0010628) | 2.35 | 2 | PLP1, ERLIN2 |
| microtubule cytoskeleton organization (GO:0000226) | 4.13 | 2 | KIAA0196, SPAST |
| cytoskeleton-dependent cytokinesis (GO:0061640) | 6.2 | 2 | KIAA0196, SPAST |
| neuron projection development (GO:0031175) | 4.58 | 2 | PLP1, ZFYVE27 |
| regulation of apoptotic process (GO:0042981) | 2.5 | 2 | HSPD1, ARL6IP1 |
| cellular macromolecule catabolic process (GO:0044265) | 3.19 | 2 | ERLIN2, VPS37A |
| immune response-regulating signaling pathway (GO:0002764) | 3.72 | 2 | HSPD1, SPG21 |
| regulation of peptidase activity (GO:0052547) | 3.75 | 2 | HSPD1, ARL6IP1 |
| positive regulation of immune system process (GO:0002684) | 2.96 | 2 | HSPD1, SPG21 |
| regulation of immune system process (GO:0002682) | 2.5 | 2 | HSPD1, SPG21 |
| glycosphingolipid metabolic process (GO:0006687) | 5.49 | 2 | B4GALNT1, GBA2 |
| regulation of molecular function (GO:0065009) | 1.78 | 2 | HSPD1, ARL6IP1 |
| cell migration (GO:0016477) | 3.12 | 2 | MAG, L1CAM |
| heterocycle biosynthetic process (GO:0018130) | 1.7 | 2 | AMPD2, IBA57 |
| sphingolipid biosynthetic process (GO:0030148) | 5.38 | 2 | FA2H, B4GALNT1 |
| cation transport (GO:0006812) | 3.11 | 2 | SLC33A1, NIPA1 |
| ion transport (GO:0006811) | 2.66 | 2 | SLC33A1, NIPA1 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 2 | HSPD1, ARL6IP1 |
| purine ribonucleotide metabolic process (GO:0009150) | 4.16 | 2 | AMPD2, NT5C2 |
| spindle organization (GO:0007051) | 5.33 | 2 | SPAST, KIAA0196 |
| macromolecule modification (GO:0043412) | 1.73 | 2 | ERLIN2, B4GALNT1 |
| protein modification process (GO:0036211) | 1.79 | 2 | ERLIN2, B4GALNT1 |
| long-chain fatty acid metabolic process (GO:0001676) | 5.27 | 2 | PLP1, CYP2U1 |
| maintenance of location (GO:0051235) | 4.77 | 2 | BSCL2, B4GALNT1 |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 2 | HSPD1, ARL6IP1 |
| proteolysis involved in cellular protein catabolic process (GO:0051603) | 3.59 | 2 | VPS37A, ERLIN2 |
| lipid particle organization (GO:0034389) | 7.09 | 2 | BSCL2, SPG20 |
| nucleoside monophosphate metabolic process (GO:0009123) | 4.54 | 2 | AMPD2, NT5C2 |
| positive regulation of nervous system development (GO:0051962) | 3.64 | 2 | MAG, L1CAM |
| negative regulation of nervous system development (GO:0051961) | 4.15 | 2 | MAG, SPG20 |
| ubiquitin-dependent protein catabolic process (GO:0006511) | 3.72 | 2 | ERLIN2, VPS37A |
| nucleotide metabolic process (GO:0009117) | 3.73 | 2 | AMPD2, NT5C2 |
| nucleoside phosphate metabolic process (GO:0006753) | 3.71 | 2 | AMPD2, NT5C2 |
| organic hydroxy compound metabolic process (GO:1901615) | 3.84 | 2 | CYP7B1, ERLIN2 |
| fatty acid biosynthetic process (GO:0006633) | 5.01 | 2 | PLP1, FA2H |
| regulation of developmental growth (GO:0048638) | 4.04 | 2 | L1CAM, SPG20 |
| purine nucleoside metabolic process (GO:0042278) | 4.32 | 2 | AMPD2, NT5C2 |
| negative regulation of cellular component organization (GO:0051129) | 3.35 | 2 | MAG, SPG20 |
| negative regulation of signaling (GO:0023057) | 2.65 | 2 | CYP7B1, SPG20 |
| substantia nigra development (GO:0021762) | 5.9 | 2 | PLP1, MAG |
| negative regulation of cell communication (GO:0010648) | 2.66 | 2 | CYP7B1, SPG20 |
| axon guidance (GO:0007411) | 4.44 | 2 | L1CAM, KIF5A |
| purine nucleoside monophosphate metabolic process (GO:0009126) | 4.69 | 2 | AMPD2, NT5C2 |
| ribonucleotide metabolic process (GO:0009259) | 4.11 | 2 | AMPD2, NT5C2 |
| cell cycle (GO:0007049) | 3.14 | 2 | ZFYVE26, SPAST |
| regulation of extent of cell growth (GO:0061387) | 5.09 | 2 | L1CAM, SPG20 |
| interspecies interaction between organisms (GO:0044419) | 3.08 | 2 | HSPD1, VPS37A |
| recombinational repair (GO:0000725) | 5.37 | 2 | ZFYVE26, AP5Z1 |
| double-strand break repair via homologous recombination (GO:0000724) | 5.38 | 2 | ZFYVE26, AP5Z1 |
| negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 2 | MAG, SPG20 |
| negative regulation of neurogenesis (GO:0050768) | 4.22 | 2 | MAG, SPG20 |
| positive regulation of neurogenesis (GO:0050769) | 3.77 | 2 | MAG, L1CAM |
| membrane lipid biosynthetic process (GO:0046467) | 4.99 | 2 | FA2H, B4GALNT1 |
| liposaccharide metabolic process (GO:1903509) | 4.98 | 2 | B4GALNT1, GBA2 |
| sterol metabolic process (GO:0016125) | 4.92 | 2 | CYP7B1, ERLIN2 |
| lipid storage (GO:0019915) | 6.4 | 2 | BSCL2, B4GALNT1 |
| modification-dependent protein catabolic process (GO:0019941) | 3.71 | 2 | VPS37A, ERLIN2 |
| cellular response to DNA damage stimulus (GO:0006974) | 3.17 | 2 | ZFYVE26, AP5Z1 |
| negative regulation of cell differentiation (GO:0045596) | 3.33 | 2 | MAG, SPG20 |
| immune response-activating signal transduction (GO:0002757) | 3.8 | 2 | HSPD1, SPG21 |
| axonogenesis (GO:0007409) | 4.74 | 2 | SPAST, ATL1 |
| bile acid metabolic process (GO:0008206) | 6.15 | 2 | CYP7B1, GBA2 |
| nucleobase-containing small molecule metabolic process (GO:0055086) | 3.59 | 2 | AMPD2, NT5C2 |
| cholesterol metabolic process (GO:0008203) | 5.03 | 2 | CYP7B1, ERLIN2 |
| protein oligomerization (GO:0051259) | 3.71 | 2 | ATL1, SPAST |
| amide biosynthetic process (GO:0043604) | 3.6 | 2 | C12orf65, B4GALNT1 |
| regulation of immune response (GO:0050776) | 2.98 | 2 | HSPD1, SPG21 |
| negative regulation of axonogenesis (GO:0050771) | 5.52 | 2 | MAG, SPG20 |
| carbohydrate derivative biosynthetic process (GO:1901137) | 3.73 | 2 | AMPD2, B4GALNT1 |
| positive regulation of cell differentiation (GO:0045597) | 3.01 | 2 | MAG, L1CAM |
| positive regulation of immune response (GO:0050778) | 3.4 | 2 | HSPD1, SPG21 |
| negative regulation of cell morphogenesis involved in differentiation (GO:0010771) | 4.96 | 2 | MAG, SPG20 |
| regulation of mitochondrion organization (GO:0010821) | 4.34 | 2 | DDHD1, DDHD2 |
| phosphatidic acid metabolic process (GO:0046473) | 6.2 | 2 | DDHD1, DDHD2 |
| phosphatidic acid biosynthetic process (GO:0006654) | 6.23 | 2 | DDHD1, DDHD2 |
| neuron projection morphogenesis (GO:0048812) | 4.34 | 2 | ATL1, SPAST |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 2 | HSPD1, ERLIN2 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 2 | ERLIN2, ARL6IP1 |
| leukocyte migration (GO:0050900) | 4.19 | 2 | MAG, L1CAM |
| IMP metabolic process (GO:0046040) | 7.09 | 2 | AMPD2, NT5C2 |
| positive regulation of mitochondrion organization (GO:0010822) | 4.61 | 2 | DDHD1, DDHD2 |
| purine-containing compound metabolic process (GO:0072521) | 4.0 | 2 | AMPD2, NT5C2 |
| modification-dependent macromolecule catabolic process (GO:0043632) | 3.69 | 2 | ERLIN2, VPS37A |
| regulation of cell death (GO:0010941) | 2.43 | 2 | HSPD1, ARL6IP1 |
| multicellular organism development (GO:0007275) | 2.54 | 2 | SPAST, L1CAM |
| endoplasmic reticulum tubular network organization (GO:0071786) | 7.53 | 2 | ARL6IP1, REEP1 |
| regulation of cysteine-type endopeptidase activity (GO:2000116) | 4.37 | 2 | HSPD1, ARL6IP1 |
| developmental maturation (GO:0021700) | 4.7 | 2 | PLP1, KIAA0196 |
| regulation of mitochondrial fission (GO:0090140) | 6.84 | 2 | DDHD1, DDHD2 |
| positive regulation of mitochondrial fission (GO:0090141) | 7.09 | 2 | DDHD1, DDHD2 |
| protein homooligomerization (GO:0051260) | 4.21 | 2 | ATL1, SPAST |
| cellular component morphogenesis (GO:0032989) | 3.5 | 2 | SPAST, ATL1 |
| regulation of programmed cell death (GO:0043067) | 2.49 | 2 | HSPD1, ARL6IP1 |
| negative regulation of apoptotic process (GO:0043066) | 3.04 | 2 | HSPD1, ARL6IP1 |
| negative regulation of programmed cell death (GO:0043069) | 3.02 | 2 | HSPD1, ARL6IP1 |
| activation of immune response (GO:0002253) | 3.67 | 2 | HSPD1, SPG21 |
| regulation of lipid metabolic process (GO:0019216) | 4.08 | 2 | ERLIN2, BSCL2 |
| regulation of endopeptidase activity (GO:0052548) | 3.8 | 2 | HSPD1, ARL6IP1 |
| autophagy (GO:0006914) | 3.82 | 2 | TECPR2, VPS37A |
| cellular protein localization (GO:0034613) | 3.11 | 2 | ARL6IP1, ZFYVE27 |
| cellular protein modification process (GO:0006464) | 1.79 | 2 | ERLIN2, B4GALNT1 |
| negative regulation of neuron projection development (GO:0010977) | 4.88 | 2 | MAG, SPG20 |
| multi-organism cellular process (GO:0044764) | 3.14 | 2 | HSPD1, VPS37A |
| cellular component disassembly (GO:0022411) | 3.52 | 2 | SPAST, C12orf65 |
| nucleoside metabolic process (GO:0009116) | 4.12 | 2 | AMPD2, NT5C2 |
| response to chemical (GO:0042221) | 1.98 | 2 | HSPD1, GJC2 |
| ribonucleoside metabolic process (GO:0009119) | 4.21 | 2 | AMPD2, NT5C2 |
| organelle assembly (GO:0070925) | 3.75 | 2 | KIAA0196, VPS37A |
| macromolecule catabolic process (GO:0009057) | 3.0 | 2 | ERLIN2, VPS37A |
| organelle localization (GO:0051640) | 3.94 | 2 | SPAST, SPG11 |
| locomotion (GO:0040011) | 2.91 | 2 | MAG, L1CAM |
| response to abiotic stimulus (GO:0009628) | 2.8 | 2 | HSPD1, MAG |
| cytoskeleton organization (GO:0007010) | 3.22 | 2 | KIAA0196, SPAST |
| cell projection morphogenesis (GO:0048858) | 4.05 | 2 | ATL1, SPAST |
| developmental process involved in reproduction (GO:0003006) | 3.36 | 2 | CYP7B1, KIAA0196 |
| establishment of protein localization to membrane (GO:0090150) | 4.14 | 2 | ARL6IP1, REEP1 |
| neural nucleus development (GO:0048857) | 5.57 | 2 | PLP1, MAG |
| ribose phosphate metabolic process (GO:0019693) | 4.06 | 2 | AMPD2, NT5C2 |
| alcohol metabolic process (GO:0006066) | 4.2 | 2 | CYP7B1, ERLIN2 |
| regulation of cell growth (GO:0001558) | 3.75 | 2 | SPG20, L1CAM |
| viral process (GO:0016032) | 3.15 | 2 | HSPD1, VPS37A |
| symbiosis, encompassing mutualism through parasitism (GO:0044403) | 3.15 | 2 | HSPD1, VPS37A |
| regulation of growth (GO:0040008) | 3.26 | 2 | L1CAM, SPG20 |